Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
101.40    -1.80 (-1.74%)
Bid:
101.40
Ask:
102.20
Spread: 0.80 (0.789%)
Market Cap: £166.24m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

14 Nov 2008 07:00

RNS Number : 1486I
Yule Catto & Co PLC
14 November 2008
 



Yule Catto & Co plc 

Interim Management Statement

Whilst 2008 started positively, the slowdown in the global economy has become ever more evident as the year has progressed.

In Polymer Chemicals, our latex business in both Europe and the Far East enjoyed good volumes particularly in nitrile. The reduced demand from the construction and coatings Industries has resulted in declining volumes in our dispersions business in Europe and South Africa. However, we have continued to see good growth in these products over the course of the year in both the Middle East and the Far East. Margins remained under pressure in the third quarter as monomer prices generally increased, though these costs are now starting to fall.

Whilst we see the Pharma business as non cyclical, we have seen volume reductions through the second half, as customers have de-stocked in response to the economic downturn, and we now expect Pharma full year profits to be below 2007. The Italian plant remains on track for closure in mid 2009 and we expect to see the benefit of that in the business results through next year.

The restructured Impact portfolio continues to perform ahead of last year, and the successful divestments of James Robinson in the first half and Holliday Pigments in the third quarter have allowed us to substantially reduce our Group borrowings.

Overall, in line with our view at the half year, we continue to expect our full year underlying profit before tax to be modestly ahead of 2007.

14 November 2008

 ENQUIRIES:

 

YULE CATTO

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

COLLEGE HILL 

Tel: 020 7457 2020 

Gareth David

email: gareth.david@collegehill.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFIDLALVLIT
Date   Source Headline
29th Sep 20227:00 amRNSTrading update
23rd Sep 20229:23 amRNSHolding(s) in Company
12th Sep 20223:27 pmRNSHolding(s) in Company
6th Sep 20228:15 amRNSHolding(s) in Company
12th Aug 20229:22 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20224:09 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.